Meeting Report
Advances in the Treatment of HER2-Positive Breast Cancer
Presented by Reshma Mahtani, DO, and Lisa Hineman, MS, AOCN®, PHN, ANP-C
Presenters’ disclosures of conflicts of interest are found at the end of this article.
Sylvester Comprehensive Cancer Center, Deerfield Beach, Florida; and Los Angeles Cancer Network, Los Angeles, California
J Adv Pract Oncol 2019;10(3):233–239 |
https://doi.org/10.6004/jadpro.2019.10.3.6 |
© 2019 Harborside™
ABSTRACT
Reshma Mahtani, DO, and Lisa Hineman, MS, AOCN®, PHN, ANP-C, reviewed landmark clinical trials of adjuvant therapies for women with HER2–positive breast cancer and emphasized the key role of advanced practitioners in managing adverse events, notably diarrhea.
For access to the full length article, please
sign in.
